Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer. - Metzger1., O.; Mandrekar, S.; Goel, S.; Gligorov, J.; Lim, E.; Ciruelos, E.; Loibl, S.; Dockter, T.; Farré, X. Gonzàlez; Francis, P. A.; Lynce, F.; Lanzillotti, J.; et al. (New England Journal of Medicine, 2026)